Position history for Capital Research Global Investors's holdings in ABBOTT LABORATORIES
Capital Research Global Investors holds 49.8M shares of ABT (ABBOTT LABORATORIES), worth $5.1B as of 2026-Q1. The position was increased (+27.1% shares). ABT represents 0.8% of Capital Research Global Investors's portfolio.
Current Value
$5.1B
Current Shares
49.8M
Total Value Change
-$837.3M
Total Shares Change
-7.5M
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 49.8M |
+27.1% |
| $5.1B |
| 0.8% |
| $113.61 |
56 |
| 2025-Q4 | Increased | 39.2M | +1.0% | $4.9B | 0.9% | $125.15 | 45 |
| 2025-Q3 | Decreased | 38.8M | -7.2% | $5.2B | 1.0% | $131.85 | 0 |
| 2025-Q2 | Decreased | 41.8M | -17.7% | $5.7B | 1.1% | $132.52 | 0 |
| 2025-Q1 | Decreased | 50.7M | -6.2% | $6.7B | 1.5% | $128.41 | 0 |
| 2024-Q4 | Increased | 54.1M | +1.5% | $6.1B | 1.3% | $110.14 | 51 |
| 2024-Q3 | Decreased | 53.3M | -6.9% | $6.1B | 1.3% | $109.27 | 0 |
| 2024-Q2 | Decreased | 57.2M | -31.9% | $5.9B | 1.3% | $100.45 | 0 |